Welcome to our dedicated page for RCIRX news (Ticker: RCIRX), a resource for investors and traders seeking the latest updates and insights on RCIRX stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RCIRX's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RCIRX's position in the market.
Regan Capital, managing over $2.2 billion in assets, announced a fee reduction for its Regan Total Return Income Fund (RCIRX). Effective January 31, 2025, the fund's Management Fee will decrease from 0.89% to 0.85%, and the Expense Cap will drop from 1.20% to 0.99%.
The fund, which focuses on high-quality, discounted mortgage bonds and active trading, recently surpassed $1 billion in assets, reaching $1.13 billion as of January 29, 2025. RCIRX has demonstrated strong performance, generating a total return of 31.17% since its October 1, 2020 inception, while the Bloomberg U.S. Aggregate Bond TR Index declined by 7.87% during the same period.
